FindTrial
Sign In

The MRI scan data of this study were first transferred to the PACS system of the hospital for preservation, and data was backed up with a hard disk, which was kept by the scientific research secretary.

The MRI scan data of this study were first transferred to the PACS system of the hospital for preservation, and data was backed up with a hard disk, which was kept by the scientific research secretary.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067462
Enrollment
Unknown
Registered
2023-01-09
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary hepatic carcinoma

Interventions

Case series:None

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Pathological diagnosis of liver malignant tumor; (2) Routine MRI, PGSE and OGSE scans were performed within 2 weeks before pathological examination.

Exclusion criteria

Exclusion criteria: 1) Liver tumors that had been treated before PGSE and OGSE sequence scanning; (2) Patients who had undergone liver puncture within 2 weeks prior to PGSE and OGSE sequence scanning; (3) PGSE and OGSE sequence post-processing cannot be performed due to poor image quality caused by motion artifacts or other reasons.

Design outcomes

Primary

MeasureTime frame
OGSE;—

Countries

China

Contacts

Public ContactXiaohui Duan

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

duanxiaohui-128@163.com13512762365

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026